Future directions for unsealed source radionuclide therapy for bone metastases.
McCready
V R
VR
O'Sullivan
J M
JM
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy* / Q000556:secondary*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D004307:Dose-Response Relationship, Radiation; D005544:Forecasting; D006801:Humans; D007275:Injections, Intravenous; D010146:Pain / Q000209:etiology; D059408:Pain Management; D011786:Quality Control; D011868:Radioisotopes / Q000008:administration & dosage* / Q000145:classification; D011878:Radiotherapy / Q000379:methods* / Q000639:trends*; D019233:Retreatment / Q000379:methods
D000970:Antineoplastic Agents; D011868:Radioisotopes